S T A T E   O F   N E W   Y O R K
________________________________________________________________________
                                  9562
                          I N  A S S E M B L Y
                             March 16, 2016
                               ___________
Introduced  by  M.  of  A. GOTTFRIED, LUPARDO, DINOWITZ, PAULIN, HEVESI,
  BLAKE, BRINDISI, COOK, ORTIZ, RUSSELL,  SEPULVEDA,  SIMON,  SKARTADOS,
  SKOUFIS,  ZEBROWSKI  --  read  once  and  referred to the Committee on
  Health
AN ACT to amend the public health law, in relation to dosing limitations
  and medical conditions permitting the medical use of marihuana
  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:
  Section 1. Subdivision 15 of section 3360 of the public health law, as
added by chapter 90 of the laws of 2014, is amended to read as follows:
  15.  "Individual dose" means a single measure of raw medical marihuana
or non-infused concentrates to be determined and clearly identified by a
patient's practitioner for the patient's specific  certified  condition.
[For ingestible or sub-lingual medical marihuana products, no individual
dose may contain more than ten milligrams of tetrahydrocannabinol.]
  S  2. Subdivision 7 of section 3360 of the public health law, as added
by chapter 90 of the laws of 2014, is amended to read as follows:
  7. [(a)] "Serious condition" means:
  (i) having one of the following severe debilitating or  life-threaten-
ing conditions: cancer, positive status for human immunodeficiency virus
or  acquired  immune deficiency syndrome, amyotrophic lateral sclerosis,
ALZHEIMER'S  DISEASE,  TRAUMATIC  BRAIN  INJURY,  DYSTONIA,  Parkinson's
disease,  multiple  sclerosis, MUSCULAR DYSTROPHY, damage to the nervous
tissue of the spinal cord  with  objective  neurological  indication  of
intractable  spasticity,  epilepsy,  WASTING  SYNDROME,  POST  TRAUMATIC
STRESS  DISORDER,  RHEUMATOID  ARTHRITIS,  LUPUS,   inflammatory   bowel
disease,  neuropathies, Huntington's disease, or as added by the commis-
sioner; [and] OR
  (ii) any of the following conditions where it is clinically associated
with, or a complication of, a condition  under  this  paragraph  or  its
treatment:  cachexia or wasting syndrome; severe or chronic pain; severe
nausea; seizures; severe or persistent muscle spasms; or such conditions
as are added by the commissioner.
 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD13610-02-6
              
             
                          
                
A. 9562                             2
  [(b) No later than eighteen months from the  effective  date  of  this
section,  the  commissioner shall determine whether to add the following
serious conditions: Alzheimer's,  muscular  dystrophy,  dystonia,  post-
traumatic stress disorder and rheumatoid arthritis.]
  S  3. This act shall take effect immediately; provided that the amend-
ments to title 5-a of article 33 of the public health law made  by  this
act  shall  not  affect  the  repeal  of  such title and shall be deemed
repealed therewith.